Abnormal expression or mutations in CD61 are linked to various diseases. For example, Glanzmann thrombasthenia is a rare genetic disorder caused by mutations in the ITGB3 gene, leading to defective platelet aggregation and increased bleeding tendency. In oncology, overexpression of CD61 in tumor cells has been implicated in the progression and metastasis of certain cancers, highlighting its role in tumor biology.
